Generic and Biosimilar Pharmaceuticals market

Generic and Biosimilar Pharmaceuticals Market, Global Outlook and Forecast 2022-2028

  • 21 April 2022
  • Life Sciences
  • 109 Pages
  • Report code : PMR-7010138

  • 4.7 (158)

Generic and Biosimilar Pharmaceuticals Market

Download FREE Report Sample

  Download Free sample

Generic and Biosimilar Pharmaceuticals Market contains market size and forecasts of Generic and Biosimilar Pharmaceuticals in Global, including the following market information:

Global Generic and Biosimilar Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Generic and Biosimilar Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Generic and Biosimilar Pharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Generic and Biosimilar Pharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Generic and Biosimilar Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Generic and Biosimilar Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Other

Global Generic and Biosimilar Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Generic and Biosimilar Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)

Tumor

Diabetes

Cardiovascular

Hemophilia

Other

Global Generic and Biosimilar Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Generic and Biosimilar Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Generic and Biosimilar Pharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Generic and Biosimilar Pharmaceuticals revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Generic and Biosimilar Pharmaceuticals Market

Leave This Empty: